Tag Archives | EirGen

Presentations: Marie Curie Actions & Euraxess, Dublin, Nov 2013

In November 2013, we held an information session in the DCU Ryan Academy as the beginning of our initiatives around Horizon 2020. There were 2 primary features of the event and the presentations are shared below.

Marie Curie Actions, which is funded by the European Commission as part of Horizon2020, is a set of 4 funding programmes aimed at developing and training Research and Innovation staff across both the industry and research community in Europe.
• You can get …

Read full story · Comments { 0 }


EirGen Pharma is a pharmaceutical company which specialises in the development, registration and commercial supply of highly potent pharmaceutical products that require high levels of containment.

The company’s purpose built high containment facility, utilising innovative isolation technology is fully licensed to develop and supply the following types of molecules in finished dosage form:

  • Oncology.
  • Immunosuppressant.
  • Prostaglandins.
  • Cytotoxins / Cytostatics.

Their state of the art facilities can also facilitate the development of moisture sensitive molecules in an environment below 30%RH. The …

Read full story · Comments { 0 }